To Top

Search By Topic

Innovation

317 Articles available
Cell and Gene Therapy

Editas Founders Start New Gene Editing Company

PAO-M05-18-NI-011
Drug Development

Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis

PR-M05-18-NI-060
Strategic Partnership

Roche Expands Partnership with 4D Molecular Therapeutics to Treat Night Blindness

PAO-M05-18-NI-001
Drug Development

BIOCAD: Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients

PR-M04-18-NI-003
Diagnostics

Development of Blood Tests for Early Cancer Detection May Be Possible

PAO-M04-18-NI-020
FDA

FDA authorizes new use of test, first to identify the emerging pathogen Candida auris

PR-M04-18-NI-93
Innovation

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

PR-M04-18-NI-81
Cardiovascular

Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases

PR-M04-18-NI-72
Immunotherapy

Immunotherapy Prior to Surgery Shows Promise in Fight Against Lung Cancer

PAO-M04-18-NI-016
Innovation

Robotic Microscope Used for Brain Surgery

PAO-M04-18-NI-014
Innovation

Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery

PR-M04-18-NI-47
NDA

Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

PR-M04-18-NI-019
Approval

Amgen Gets Expanded Approval for Blincyto®

PAO-M04-18-NI-005
Radio-Conjugates

Companies Join Forces to Develop Novel Radio-Conjugates

PAO-M04-18-NI-002
Innovation

Spinal Resources, Inc.® Announces First Implantation with Swedge™ Pedicle Screw System

PR-M04-18-NI-008
Innovation

VICAM Introduces a New Method for BPA Detection

PR-M04-18-NI-004
HIV

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

PR-M03-18-NI-111
Oncology

Outcome Health And The Colorectal Cancer Alliance Announce Campaign To Support Patient Education

PR-M03-18-NI-109
Clinical Data

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

PR-M03-18-NI-095
Blockbuster

Pace of Pharmaceutical Innovation Accelerates as Record Number of New Blockbuster Drugs Forecast to Hit the Market in 2018

PR-M03-18-NI-092
Discovery

New ALS Gene Discovered: KIF5A

PR-M03-18-NI-091
Cannibis

Medical Marijuana Moves to the Big Time

PAO-M03-18-NI-019
Vaccine

Shingrix Vaccine Available at CVS

PAO-M03-18-NI-018
Anti-Aging

Additional Funding for Unity’s First Human Clinical Study

PAO-M03-18-NI-016
Artificial Intelligence

Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

PR-M03-18-NI-052
Innovation

Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform

PR-M03-18-NI-047
Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PAP-Q1-18-CL-004
Formulation

Investing in New Technologies for Innovative Functional Solutions

PAP-Q1-18-CL-009
Innovation

Death to Cleanrooms in Biopharmaceutical Manufacturing

PAP-Q1-18-CL-006
Fermentation

Focused on Fermentation

PAP-Q1-18-CL-007
Innovation

Dell Boomi, Nalta.com and digitalAngel partner to revolutionise the future of healthcare

PR-M03-18-NI-034
Digital

Novartis in Collaboration to Develop Software Applications

PAO-M03-18-NI-006
Healthcare

Orion Health Unveils New Predictive Intelligence Using Machine Learning to Help Save Billions in Healthcare Costs

PR-M03-18-NI-032
Innovation

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

PR-M03-18-NI-026
Acquistion

Bruker Gains Access to QCL Technology with IRM2 Acquisition

PAO-M03-18-NI-004
Artificial Intelligence

Philips launches AI platform for healthcare

PR-M03-18-NI-016
Oncology

Charles River Laboratories Announces New Online Tool

PAO-M03-18-NI-003
Innovation

Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea

PR-M03-18-NI-011
Innovation

Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use

PR-M03-18-NI-005
Strategic Collaboration

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

PR-M02-18-NI-93
Acquisition

Roche Pays $1.9 Billion to Acquire Flatiron Health

PAO-M02-18-NI-021
Robotics

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

PR-M02-18-NI-91
Influenza

GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age

PR-M02-18-NI-87
Clinical Trials

Aimmune’s AR101 Meets Phase 3 Endpoints

PAO-M02-18-NI-020
Oncology

Device Plus Drug Approved for Bladder Cancer Detection

PAO-M02-18-NI-018
Drug Development

Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

PR-M02-18-NI-79
Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016
FDA

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment

PR-M02-18-NI-75
Approval

Celltrion Receives EU Approval for Trastuzumab Biosimilar

PR-M02-18-NI-71
Priority Review

U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib

PR-M02-18-NI-52
Generics

The Path Toward Generics: 2017’s Record-Breaking Year

PAO-M02-18-NI-015
Drug Development

WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development

PR-M02-18-NI-049
Drug Development

AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™

PR-M02-18-NI-044
Award

Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative

PR-M02-18-NI-040
Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

PR-M02-18-NI-024
Innovation

Thermo Fisher Scientific Receives Manufacturing Leaders' Innovation Award

PR-M02-18-NI-023
Healthcare

Leading Companies Taking Action to Address Healthcare

PAO-M02-18-NI-005
Animal Nutrition

Versamaris JV Formed by DSM and Evonik

PAO-M02-18-NI-004
Biosimilars

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

PR-M01-18-NI-092
Licensing

Grace Licenses UNIPOL® PP Process Technology to Grupa Azoty in Poland

PR-M01-18-NI-090
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Cell and Gene Therapy

Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities

PAO-M01-18-NI-042
Drug Discovery

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

PR-M01-18-NI-073
Clinical Trial

Amgen and Novartis Reach an Important Milestone

PAO-M01-18-NI-041
Launch

GSK Launches Three-in-One HIV Pill in China

PAO-M01-18-NI-040
Approval

LYNPARZA® (olaparib) Receives Approval in Japan for the Treatment of Advanced Ovarian Cancer

PR-M01-18-NI-078
Biosimilar

European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer

PR-M01-18-NI-077
Opadry System

Colorcon, Inc. Transforms the Sugar Coating Process with a New Opadry System

PR-M01-18-NI-071
Strategic Collaboration

NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

PR-M01-18-NI-075
FDA Approval

FDA to Expand the Use of Gilotrif

PAO-M01-18-NI-038
Launch

Roche launches CE-marked VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer

PR-M01-18-NI-068
Technology

Thermo Fisher Scientific Announces More Than 30 Orders for Ion GeneStudio S5 One Week After Debut

PR-M01-18-NI-067
Research

Lustgarten Foundation Awarded $22 Million For Pancreatic Cancer Research

PR-M01-18-NI-066
Innovation

Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs

PAO-M01-18-NI-034
Launch

DSM Sinochem Pharmaceuticals successfully launches Rosuvastatin finished dosage formulation in Western Europe

PR-M01-18-NI-054
Bioprinting

Sebaceous Glands in 3D

PAO-M01-18-NI-029
Oncology

Olympus PeriView FLEX TBNA Needle Brings New Capabilities to Early Diagnosis of Lung Disease

PR-M01-18-NI-056
Digital Platform

Clinical Decision-support Software to be Developed by Roche and GE Healthcare

PAO-M01-18-NI-028
Innovation

CIMZIA® (certolizumab pegol) Label Change Marks Important Advance for European Women of Childbearing Age With Chronic Rheumatic Disease

PR-M01-18-NI-036
Strategic Collaboration

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology

PR-M01-18-NI-033
Breakthrough Therapy

Eisai and Merck Receive Breakthrough Therapy Designation from FDA for LENVIMA® (lenvatinib mesylate) and KEYTRUDA® (pembrolizumab) as Combination Therapy 

PR-M01-18-NI-032
Development Agreement

Arvinas Protein Degradation Technology Attracts Pfizer’s Attention

PAO-M01-18-NI-020
Cannibis

California Legalizes Cannabis with Canada Looming

PR-M01-18-NI-030
Drug Development

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

PR-M01-18-NI-029
Announcement

Taxus Cardium Announces Name Change To Gene Biotherapeutics

PR-M01-18-NI-021
Drug Development

Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs

PR-M01-18-NI-024
Licensing Agreement

Generex Biotech and Shenzhen BioScien Enter into Licensing Agreement

PAO-M01-18-NI-014
Drug Development

PPD® Laboratories Named a Top Innovator in Drug Development

PR-M01-18-NI-016
CDMO

Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

PR-M01-18-NI-015
Drug Development

Promacta Gets Breakthrough Therapy Designation

PAO-M01-18-NI-012
Biologics

New Class of Exosome Biologics Focuses on Stroke Treatment

PAO-M01-18-NI-011
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Immunotherapy

Deal with Inovio Launches ApolloBio’s Commercialization Plans in China

PAO-M01-18-NI-009
CRISPR

Genetically Engineered Horses Could be a Reality

PAO-M01-18-NI-008
CAR T

Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents

PAO-M01-18-NI-006
Business

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

PR-M01-18-NI-009
Innovation

New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices

PR-M01-18-NI-008
Business

PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors

PR-M01-18-NI-007
Business

Cue Biopharma Announces Closing of Initial Public Offering

PR-M01-18-NI-003
Clinical Trials

Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018

PR-M01-18-NI-002
FDA Guidance

FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity

PAO-M01-18-NI-004
Drug Delivery

Building DNA and RNA Origami for Drug Delivery

PAO-M01-18-NI-003
Strategic Partnership

Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma

PAO-M01-18-NI-002
Acquisition

Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs

PAO-M01-18-NI-001
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
Artificial Intelligence

New Platform Brings AI Efficiency to Health Data Processing

PAO-M12-17-NI-036
Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

PAO-M12-17-NI-037
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
FDA

NDA Submitted for Antimalarial Drug

PAO-M12-17-NI-034
Strategic Partnership

BioVectra and Keryx Expand Strategic API Supply Relationship

PAO-M12-17-NI-030
Added Capacity

World’s Largest Biologics Plant Gets EMA Nod

PAO-M12-17-NI-029
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Oncology

Altering White Blood Cells to Kill Cancer

PAO-M12-17-NI-026
Drug Development

Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties

PAO-M12-17-NI-025
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
CRISPR

Charles River Expands CRISPR Offerings with Second License

PAO-M12-17-NI-022
Innovation

Molex Expands Strategic Investment Platform with Venture Initiative

PR-M12-17-NI-011
Innovation

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

PR-M12-17-NI-007
Oncology

Phase III Study Confirms AbbVie Leukemia Combo Meets Endpoint

PAO-M12-17-NI-021
Drug Development

New Generic for Kenalog-40 Approved

PAO-M12-17-NI-020
3D Printing

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

PAO-M12-17-NI-018
Hemophilia

Results of New Gene Therapy Revealed at Hemophilia Meeting

PAO-M12-17-NI-017
Drug Development

ZUMA-1 Study of Yescarta Reports 58% Complete Remission

PAO-M12-17-NI-016
Immunotherapy

Phase II Results Reveal High-Performance Immunotherapy

PAO-M12-17-NI-015
Innovation

Bioinformatics Solutions, Inc. Chooses Science Exchange as the Primary Online Channel to Offer Protein de novo Sequencing Services to Scientists

PR-M12-17-NI-005
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010